Evaluation of the efficacy and safety of inhaled magnesium sulphate in combination with standard treatment in patients with moderate or severe COVID-19: A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
5 Jan 2021	Submitted	Original manuscript
7 Jan 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
7 Jan 2021	Editorially accepted
18 Jan 2021	Article published	10.1186/s13063-021-05032-y

Back to article page